Trexquant Investment’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Trexquant Investment’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,634	Closed	-$126K	–	1176
2019 Q2	$126K	Buy	+14,634	New	+$131K	0.01%	735
2019 Q1	–	Sell	-10,061	Closed	-$88K	–	1399
2018 Q4	$88K	Sell	10,061 -8,723	-46%	-$111K	0.01%	993
2018 Q3	$316K	Buy	+18,784	New	+$407K	0.02%	676
2017 Q4	–	Sell	-31,855	Closed	-$448K	–	1306
2017 Q3	$448K	Buy	+31,855	New	+$288K	0.11%	317
2016 Q4	–	Sell	-77,927	Closed	-$364K	–	1186
2016 Q3	$364K	Buy	77,927 +32,350	+71%	+$192K	0.08%	402
2016 Q2	$299K	Buy	+45,577	New	+$322K	0.04%	667
2016 Q1	–	Sell	-71,518	Closed	-$431K	–	1236
2015 Q4	$431K	Sell	71,518 -40,982	-36%	-$234K	0.04%	735
2015 Q3	$672K	Sell	112,500 -27,600	-20%	-$192K	0.06%	604
2015 Q2	$958K	Buy	+140,100	New	+$890K	0.11%	344
2015 Q1	–	Sell	-103,900	Closed	-$720K	–	1245
2014 Q4	$720K	Buy	+103,900	New	+$764K	0.13%	299

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trexquant Investment's SPPI Position: Q3 2019 in Review

Trexquant Investment sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2019, closing a stake of 14,634 shares — an estimated $126K sold.

Trexquant Investment first reported a position in SPPI in Q4 2014 and held it in 10 quarters. The position peaked at $958K in Q2 2015. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

Trexquant Investment reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
Trexquant Investment sold 14,634 Spectrum Pharmaceuticals Inc shares in Q3 2019, an estimated $126K.
Trexquant Investment first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 10 quarters.
Trexquant Investment's Spectrum Pharmaceuticals Inc position peaked at $958K in Q2 2015.
167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Trexquant Investment's 13F filing for Q3 2019, filed 8 Nov 2019.